Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
American Journal of Cancer Research|June 13, 2022
Chk1 inhibitor-induced DNA damage increases BFL1 and decreases BIM but does not protect human cancer cell lines from Chk1 inhibitor-induced apoptosisAndrew J MasseyPlos One|April 5, 2018
A high content, high throughput cellular thermal stability assay for measuring drug-target engagement in living cellsAndrew J MasseyScientific Reports|October 25, 2016
Tumour growth environment modulates Chk1 signalling pathways and Chk1 inhibitor sensitivityAndrew J MasseyScientific Reports|January 21, 2017
Modification of tumour cell metabolism modulates sensitivity to Chk1 inhibitor-induced DNA damageAndrew J MasseyCancer Letters|October 4, 2016
Inhibition of ATR-dependent feedback activation of Chk1 sensitises cancer cells to Chk1 inhibitor monotherapyAndrew J MasseyPlos One|July 29, 2015
Multiparametric Cell Cycle Analysis Using the Operetta High-Content Imager and Harmony Software with PhenoLOGICAndrew J MasseyBMC Cancer|July 6, 2014
γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatmentsRebecca Rawlinson, Andrew J MasseySLAS Discovery : Advancing Life Sciences R & D|October 20, 2017
Cell Density Affects the Detection of Chk1 Target Engagement by the Selective Inhibitor V158411Clara C Geneste, Andrew J MasseyBMC Cancer|August 9, 2014
Chk1 inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancersChristopher Bryant, Rebecca Rawlinson, Andrew J MasseyMolecular Cancer Research : MCR|December 13, 2012
Knockdown of PAK4 or PAK1 inhibits the proliferation of mutant KRAS colon cancer cells independently of RAF/MEK/ERK and PI3K/AKT signalingHana Tabusa, Teresa Brooks, Andrew J MasseyPageof 3